搜索临床试验以:camrelizumab;Rivoceranib
总计436个结果
-
Jiangsu HengRui Medicine Co., Ltd.终止
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人根治性切除或消融后复发风险高的肝细胞癌 (HCC) 患者的辅助治疗中国
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Huashan HospitalJiangsu HengRui Medicine Co., Ltd.; Shanghai Sunstem Biotechnology Co., Ltd.招聘中
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Henan Provincial People's Hospital尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.完全的
-
The Second Affiliated Hospital of Shandong First...招聘中
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Zhang Bi Xiang, MD招聘中
-
Wuhan Union Hospital, ChinaJiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Shanghai Pulmonary Hospital, Shanghai, China招聘中
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.尚未招聘
-
Sun Yat-sen UniversityWuzhou Red Cross Hospital; Fifth Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer... 和其他合作者招聘中
-
Peking UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Third Affiliated Hospital, Sun Yat-Sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.招聘中
-
Jiangsu HengRui Medicine Co., Ltd.完全的局部晚期或转移性和不可切除的 HCC美国, 西班牙, 中国, 台湾, 比利时, 大韩民国, 意大利, 香港, 俄罗斯联邦, 乌克兰, 火鸡, 波兰, 德国
-
Zhejiang Cancer Hospital尚未招聘胃癌、HIPEC、抗 PD-1 抗体 Camrelizumab (SHR-1210)、化疗和手术中国
-
First Affiliated Hospital Xi'an Jiaotong UniversityJiangsu HengRui Medicine Co., Ltd.未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityGuangdong Provincial People's Hospital; Third Affiliated Hospital, Sun Yat-Sen University招聘中
-
Hospital of Stomatology, Wuhan UniversityJiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Xinrui Zhu邀请报名不可切除的肝细胞癌 | 酪氨酸激酶抑制剂 | 经动脉化疗栓塞 | 免疫检查点封锁中国